ARTL
Artelo BiosciencesCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
ARTL vs peer average
61/100
ARTL vs. peer average (C vs. D)
Grade spread
A 1 · B 1 · C 2 · D 2 · F 4
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
RGNX is the first available peer comparator.
Biotech whose valuation is driven by binary clinical readouts and partnership outcomes, offering a comparably high event risk/reward profile.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ARTL
Artelo Biosciences
RGNX
REGENXBIO
Grade
C
A
Momentum
1
98
Value
58
41
Sentiment
93
59
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs RGNX
ARTL / RGNX
Grade Position
In line
ARTL vs. peer average (C vs. D)
61/100
Momentum
1
RGNXValue
58
ARTLSentiment
93
ARTLRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ARTL
RGNX is the first peer returned for this comparison set.